Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2022

Publisher Name :
Date: 05-Jul-2022
No. of pages: 90
Inquire Before Buying

Market Analysis and Insights: Global Molecular Diagnostics in Infectious Disease Testing Market

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.

The global Molecular Diagnostics in Infectious Disease Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics in Infectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics in Infectious Disease Testing market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics in Infectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics in Infectious Disease Testing market.

Global Molecular Diagnostics in Infectious Disease Testing Scope and Market Size

Molecular Diagnostics in Infectious Disease Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics in Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Polymerase Chain Reaction (PCR)

- Isothermal Nucleic Acid Amplification Technology (INAAT)

- Microarrays

- Next-Generation Sequencing (NGS)

- Hybridization

- Others

Segment by Application

- Hospitals

- Clinics

- Academic Institutes

- Laboratories

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Abbott

- BD

- BioMerieux

- Thermo Fisher Scientific

- Roche

- Siemens

- Veridex

- Luminex

- GenMark Diagnostics

- Qiagen

- Genomix Biotech

- BioTheranostics

Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.4 Microarrays
1.2.5 Next-Generation Sequencing (NGS)
1.2.6 Hybridization
1.2.7 Others
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Perspective (2017-2028)
2.2 Molecular Diagnostics in Infectious Disease Testing Growth Trends by Region
2.2.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics in Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue (2017-2022)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2021
3.5 Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2017-2022)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
6.2 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022)
6.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
9.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022)
9.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
11.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.2.5 BD Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
11.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.3.5 BioMerieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
11.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.5.5 Roche Recent Development
11.6 Siemens
11.6.1 Siemens Company Detail
11.6.2 Siemens Business Overview
11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
11.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.6.5 Siemens Recent Development
11.7 Veridex
11.7.1 Veridex Company Detail
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Detail
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
11.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.10.5 Qiagen Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Detail
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Detail
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.12.5 BioTheranostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 4. Key Players of Microarrays
Table 5. Key Players of Next-Generation Sequencing (NGS)
Table 6. Key Players of Hybridization
Table 7. Key Players of Others
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2017-2022)
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2023-2028)
Table 14. Molecular Diagnostics in Infectious Disease Testing Market Trends
Table 15. Molecular Diagnostics in Infectious Disease Testing Market Drivers
Table 16. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 17. Molecular Diagnostics in Infectious Disease Testing Market Restraints
Table 18. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2017-2022)
Table 20. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2021)
Table 21. Ranking of Global Top Molecular Diagnostics in Infectious Disease Testing Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
Table 25. Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2017-2022)
Table 29. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2023-2028)
Table 31. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2017-2022)
Table 33. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2023-2028)
Table 35. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 45. Abbott Company Detail
Table 46. Abbott Business Overview
Table 47. Abbott Molecular Diagnostics in Infectious Disease Testing Product
Table 48. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 49. Abbott Recent Development
Table 50. BD Company Detail
Table 51. BD Business Overview
Table 52. BD Molecular Diagnostics in Infectious Disease Testing Product
Table 53. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 54. BD Recent Development
Table 55. BioMerieux Company Detail
Table 56. BioMerieux Business Overview
Table 57. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product
Table 58. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 59. BioMerieux Recent Development
Table 60. Thermo Fisher Scientific Company Detail
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product
Table 63. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 64. Thermo Fisher Scientific Recent Development
Table 65. Roche Company Detail
Table 66. Roche Business Overview
Table 67. Roche Molecular Diagnostics in Infectious Disease Testing Product
Table 68. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 69. Roche Recent Development
Table 70. Siemens Company Detail
Table 71. Siemens Business Overview
Table 72. Siemens Molecular Diagnostics in Infectious Disease Testing Product
Table 73. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 74. Siemens Recent Development
Table 75. Veridex Company Detail
Table 76. Veridex Business Overview
Table 77. Veridex Molecular Diagnostics in Infectious Disease Testing Product
Table 78. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 79. Veridex Recent Development
Table 80. Luminex Company Detail
Table 81. Luminex Business Overview
Table 82. Luminex Molecular Diagnostics in Infectious Disease Testing Product
Table 83. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 84. Luminex Recent Development
Table 85. GenMark Diagnostics Company Detail
Table 86. GenMark Diagnostics Business Overview
Table 87. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product
Table 88. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 89. GenMark Diagnostics Recent Development
Table 90. Qiagen Company Detail
Table 91. Qiagen Business Overview
Table 92. Qiagen Molecular Diagnostics in Infectious Disease Testing Product
Table 93. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 94. Qiagen Recent Development
Table 95. Genomix Biotech Company Detail
Table 96. Genomix Biotech Business Overview
Table 97. Genomix Biotech Molecular Diagnostics in Infectious Disease TestingProduct
Table 98. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 99. Genomix Biotech Recent Development
Table 100. BioTheranostics Company Detail
Table 101. BioTheranostics Business Overview
Table 102. BioTheranostics Molecular Diagnostics in Infectious Disease TestingProduct
Table 103. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 104. BioTheranostics Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type: 2021 VS 2028
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Isothermal Nucleic Acid Amplification Technology (INAAT) Features
Figure 4. Microarrays Features
Figure 5. Next-Generation Sequencing (NGS) Features
Figure 6. Hybridization Features
Figure 7. Others Features
Figure 8. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application in 2021 & 2028
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region: 2021 VS 2028
Figure 18. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2021
Figure 19. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2021
Figure 21. North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2017-2028)
Figure 23. United States Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2017-2028)
Figure 27. Germany Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2017-2028)
Figure 35. China Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2017-2028)
Figure 43. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2017-2028)
Figure 47. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 50. BD Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 51. BioMerieux Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 53. Roche Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 54. Siemens Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 55. Veridex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 56. Luminex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 57. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 58. Qiagen Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 59. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 60. BioTheranostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
  • Global Molecular Diagnostic Market Analysis 2017-2022 and Forecast 2023-2028
    Published: 20-Dec-2022        Price: US 2980 Onwards        Pages: 90
    Snapshot Molecular diagnostics is growing rapidly. Molecular diagnostic tests detect specific sequences in DNA or RNA that may or may not be associated with disease, including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions and others. Clinical applications can be found in at least six general areas: infectious diseases; oncology; pharmacogenomics; genetic disease screening; human leukocyte antigen typing; and coagulation. The global Molecular Diagnostic......
  • Global Molecular Diagnostics Partnering Terms and Agreements 2015 to 2022
    Published: 01-Dec-2022        Price: US 3995 Onwards        Pages: 550
    The Global Molecular Diagnostics Partnering Terms and Agreements 2015-2022 report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest molecular diagnostics agreements announced in the life sciences since 2015. The report takes the reader through a comprehe......
  • Global Molecular Diagnostic Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 17-Nov-2022        Price: US 3450 Onwards        Pages: 96
    The report focuses on the Molecular Diagnostic market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. More......
  • Global Molecular Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 08-Nov-2022        Price: US 5600 Onwards        Pages: 114
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Molecular Diagnostics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry exp......
  • Global Molecular Diagnostics in Infectious Disease Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 03-Oct-2022        Price: US 5600 Onwards        Pages: 113
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Molecular Diagnostics in Infectious Disease Testing companies, distributors, end users, industry associations, governments' industry bureaus, indus......
  • Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 29-Sep-2022        Price: US 3450 Onwards        Pages: 107
    The report focuses on the Molecular Diagnostics in Infectious Disease Testing market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications......
  • Global POC Molecular Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 21-Sep-2022        Price: US 5600 Onwards        Pages: 109
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the POC Molecular Diagnostics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry......
  • Global Molecular Diagnostics Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Sep-2022        Price: US 3450 Onwards        Pages: 114
    The report focuses on the Molecular Diagnostics market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Mor......
  • Global POC Molecular Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028
    Published: 16-Aug-2022        Price: US 3480 Onwards        Pages: 103
    The POC Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our (Globa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs